® Consulta de Marcas Base do INPI · pesquisa e monitoramento

CELULARITY

Registro de marca em vigor (Madri)

Marca Nominativa depositada no INPI em 11/08/2022 por Celularity Inc., processo nº 501692918, nas classes 01, 05, 40, 42. Registro em vigor até 11/08/2032.

Número do processo501692918
SituaçãoRegistro de marca em vigor (Madri)
ApresentaçãoNominativa
NaturezaMadri Produto/Serviço
Data do depósito11/08/2022
Data da concessão16/01/2024
Vigência até11/08/2032
TitularCelularity Inc.
CNPJ/CPF do titular
UF · País— · US

Classes e especificação

Classe 01 — Produtos químicos

Bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research.;

Classe 05 — Farmacêuticos e saúde

Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cord cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen; biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen.;

Classe 40 — Tratamento de materiais

Custom manufacturing services of biopharmaceuticals and gene and cell therapy products, namely, genetically engineered tissues for others; custom manufacturing services for others in the fields of mammalian cell banks, plasmids, purified mitochondria, cell lysates; custom production of cells for others; custom manufacturing of cells for others; advanced cell custom manufacturing for others; manufacturing process consulting.;

Classe 42 — Tecnologia e pesquisa

Research, development and testing services for others in the fields of genomics, biotechnology and pharmaceuticals; stem cell research services; research, development and testing services in the fields of genomics, biotechnology and pharmaceuticals, namely, collection, testing, processing, preservation, storage and retrieval of cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; laboratory research services in the field of genomics, biotechnology and pharmaceuticals consisting of collection, testing, processing, preservation, storage and retrieval of bioengineered cells, human allograft tissue made from human umbilical cords and human placentas, human amniotic membrane and human chorionic membrane, human collagen and extracellular matrix compositions; technical writing and providing information via a website in the field of medical research relating to banking stem cells and cord blood banking; biological research, namely, biosourcing of clinically accessible, immune-tolerant human stem and progenitor and other postpartum placenta-derived cell populations and tissues for medical research; medical research to find methods to restore the structure and function of damaged or diseased tissues and organs, including wound care, reconstructive medicine, whole organ and tissue regeneration and renewal; medical research regarding emergent cell therapies; medical research regarding allogeneic immunotherapy; providing on-line information, news and commentary in the field of medical research relating to the foregoing.;

Acompanhe este processo

Receba um e-mail a cada novo despacho publicado na RPI para o processo 501692918 — exigência, oposição, deferimento, prazo de pagamento — e quando alguém depositar uma marca parecida.

Monitorar esta marca Ver marcas parecidas

Andamento do processo no INPI

4 despacho(s) publicado(s) na Revista da Propriedade Industrial.

  1. 16/01/2024 Concessão de registro em designação código IPAS770 · RPI 2767
  2. 26/09/2023 Deferimento de designação código IPAS768 · RPI 2751
  3. 28/03/2023 Publicação de pedido de registro para oposição (exame formal de designação concluído) código IPAS756 · RPI 2725
  4. 28/03/2023 Deferimento da petição <b>Protocolo:</b> 850230086382 (27/02/2023) <br /> <b>Petição (tipo):</b> Nomeação, destituição ou substituição de procurador [em processo de registro] (385.1)<br /><b>Requerente: </b>CELULARITY INC.<br /><b>Procurador: </b>MSANTOS PROPRIEDADE INTELECTUAL LTDA - EPP<br /><b>Detalhes do despacho:</b>Nomeado procurador MSANTOS PROPRIEDADE INTELECTUAL LTDA - EPP com poderes para representar o titular do processo perante o INPI.<br /> código IPAS270 · RPI 2725